Galimedix, Inc. | WebDisclosure

Basculer en Français

10158	Companies
208664	Keywords
138749	Articles
110583	Press releases

Home
Companies
Galimedix, Inc.

BRIEF

published on 03/20/2026 at 08:05, 14 days 3 hours ago

Galimedix dévoile un promédicament prometteur contre la maladie d'Alzheimer lors du congrès AD/PD™ 2026

Traitement De La Maladie D'Alzheimer Thérapeutique Galimedix Profil Pharmacocinétique Promédicament Oral Thérapie Neuroprotectrice
BRIEF

published on 03/20/2026 at 08:05, 14 days 3 hours ago

Galimedix Unveils Promising Alzheimer’s Prodrug at AD/PD™ 2026

Galimedix Therapeutics Pharmacokinetic Profile Alzheimer’s Treatment Neuroprotective Therapy Oral Prodrug
PRESS RELEASE

published on 03/20/2026 at 08:00, 14 days 3 hours ago

Galimedix Therapeutics presents strong pharmacokinetic profile of next-generation oral Alzheimer’s candidate at AD/PD™ 2026
Galimedix Therapeutics presents strong pharmacokinetic profile of next-generation oral Alzheimer's candidate at AD/PD™ 2026, demonstrating improved absorption and systemic exposure for patient-friendly dosing

Alzheimer's Disease Galimedix Therapeutics Pharmacokinetic Profile Oral Alzheimer's Candidate AD/PD™ 2026
BRIEF

published on 03/12/2026 at 13:05, 21 days 22 hours ago

Galimedix Therapeutics obtient un paiement d'étape dans le cadre de son partenariat avec Théa

Thérapeutique Galimedix Théa Open Innovation Essais GAL-101 Partenariat En Ophtalmologie Progrès De La Maladie D'Alzheimer
BRIEF

published on 03/12/2026 at 13:05, 21 days 22 hours ago

Galimedix Therapeutics Secures Milestone Payment in Partnership with Théa

Galimedix Therapeutics Théa Open Innovation GAL-101 Trials Ophthalmology Partnership Alzheimer's Advancement
PRESS RELEASE

published on 03/12/2026 at 13:00, 21 days 22 hours ago

Galimedix Therapeutics earns milestone payment in ophthalmology partnership with Théa Open Innovation
Galimedix Therapeutics earns milestone payment in ophthalmology partnership with Théa Open Innovation, advancing oral therapy for eye diseases and Alzheimer’s

Phase 1 Trial Alzheimer's Disease Galimedix Therapeutics Milestone Payment Ophthalmology Partnership
BRIEF

published on 03/05/2026 at 14:05, 28 days 21 hours ago

Galimedix Therapeutics présentera un nouveau modulateur de la protéine bêta-amyloïde lors du congrès AD/PD 2026

Maladies Neurodégénératives Bêta-amyloïde Pharmacocinétique Thérapeutique Galimedix Conférence AD/PD 2026
BRIEF

published on 03/05/2026 at 14:05, 28 days 21 hours ago

Galimedix Therapeutics to Showcase New Amyloid Beta Modulator at AD/PD 2026

Neurodegenerative Disorders Galimedix Therapeutics Pharmacokinetics Amyloid Beta AD/PD 2026 Conference
PRESS RELEASE

published on 03/05/2026 at 14:00, 28 days 21 hours ago

Galimedix Therapeutics to present promising pre-clinical data with next generation oral amyloid beta aggregation modulator at AD/PD™ 2026 Conference
Galimedix Therapeutics to present pre-clinical data on new oral amyloid beta modulator at AD/PD™ 2026 Conference, discussing GAL-201 prodrugs and improved pharmacokinetics

Galimedix Therapeutics Pre-clinical Data Pharmacokinetic Profile Oral Amyloid Beta Modulator AD/PD™ 2026 Conference
BRIEF

published on 12/04/2025 at 20:20, 3 months 29 days ago

Galimedix Therapeutics Reveals Promising Phase 1 Results for GAL-101

Phase 1 Results GAL-101 Alzheimer’s Treatment Blood-brain Barrier Phase 2 Planning

1 2 ... 5

Accesswire

Published on 04/02/2026 at 22:00, 13 hours 48 minutes ago

Star Copper Announces Closing of Charity Flow-Through Unit Private Placement
Published on 04/02/2026 at 18:32, 17 hours 16 minutes ago

Datavault AI CEO Nathaniel Bradley to Present DataValue(R), DataScore(R), and Information Data Exchange(R) Technologies at XRP Tokyo 2026
Published on 04/02/2026 at 15:00, 20 hours 48 minutes ago

Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress
Published on 04/02/2026 at 14:40, 21 hours 8 minutes ago

Northfield Capital Completes Acquisition Of Additional Interest In Juno Corp. And Announces Issuance Of Class B Multiple Voting Shares
Published on 04/02/2026 at 14:30, 21 hours 18 minutes ago

Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution

View all ACCESSWIRE

EQS Group

Published on 04/03/2026 at 11:05, 43 minutes ago

Hoymiles Bolsters European Plug-in Solar & Storage Market with HiFlow & HiFlow Pro Microinverters
Published on 04/03/2026 at 10:20, 1 hour 28 minutes ago

McDonald's Türkiye Introduces 'Archie' for Gamers
Published on 04/03/2026 at 08:55, 2 hours 52 minutes ago

EPH Group AG Secures Premium Resort Project in Vorarlberg
Published on 04/03/2026 at 08:10, 3 hours 38 minutes ago

UnionPay Launches Agentic Payment Open Protocol Framework: Building an Open, Trusted Smart Payment Ecosystem
Published on 04/03/2026 at 07:05, 4 hours 43 minutes ago

JINRO Unveils JINRO MELON LIMITED EDITION: A Premium Fusion of Sweetness and Sophistication

Les Echos

Published on 04/02/2026 at 18:39, 17 hours 9 minutes ago

Mersen: Disclosure of trading own shares
Published on 04/02/2026 at 18:39, 17 hours 9 minutes ago

Mersen : Déclaration des transactions sur actions propres
Published on 04/02/2026 at 18:30, 17 hours 18 minutes ago

Thales met à disposition son Document d’Enregistrement Universel 2025
Published on 04/02/2026 at 18:30, 17 hours 18 minutes ago

Thales makes available its Universal Registration Document 2025
Published on 04/02/2026 at 18:22, 17 hours 26 minutes ago

TF1 - Déclaration mensuelle des actions et droits de vote - Mars 2026

View all LES ECHOS COMFI WIRE